Today it was reported that a Director at Resmed Inc (RMD), John Wareham, exercised options to sell 44,342 RMD shares at $51.25 a share, for a total transaction value of $5.05M.
Following John Wareham’s last RMD Sell transaction on January 29, 2018, the stock climbed by 13.2%.
See today’s analyst top recommended stocks >>
Based on Resmed Inc’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $662 million and quarterly net profit of $105 million. In comparison, last year the company earned revenue of $592 million and had a net profit of $110 million. RMD’s market cap is $16.33B and the company has a P/E ratio of 36.94. Currently, Resmed Inc has an average volume of 1.21M.
Based on 3 analyst ratings, the analyst consensus is Hold with an average price target of $80.00, reflecting a -29.4% downside.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
